» Articles » PMID: 40019720

Adipose-derived Stem Cells Enhance the Tumorigenic Potential of Pre-malignant Breast Epithelial Cells Through Paracrine Activation of PI3K-AKT Pathway

Overview
Journal Breast Cancer
Specialty Oncology
Date 2025 Feb 28
PMID 40019720
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adipose-derived stem cells (ADSCs)-assisted fat grafting has emerged as a widely used procedure for breast reconstruction post mastectomy and for aesthetic augmentation. Given the limited cases of breast cancer following grafting, the oncological safety of this procedure remains controversial.

Methods: The effects of ADSCs on the oncogenic features of premalignant MCF-10AT cells were investigated using co-culture and xenograft models. We further evaluated the malignancy-promoting effect of ADSCs in a 7,12-Dimethylbenz(a)anthracene (DMBA)-induced breast cancer model. RNA-sequencing was performed on ADSCs, MCF-10AT cells, and ADSC-co-cultured MCF-10AT cells. Protein changes in ADSC/MCF-10AT co-culture medium and MCF-10AT cells were determined by proteomic analysis. Pathway inhibitors were used to investigate signaling pathways involved in the ADSC-induced oncogenic changes of MCF-10AT cells.

Results: We found that ADSCs promoted the proliferation and migration of MCF-10AT cells, and co-injection of ADSCs increased the tumor incidence of MCF-10AT cells from 29% to 58% in nude mice. Additionally, grafted ADSCs significantly enhanced tumor incidence, growth, and distant metastasis in the DMBA-induced rats, while it could not induce tumorigenesis in normal breast tissues. Combined RNA-sequencing and proteomic analysis demonstrated that the paracrine factors secreted by ADSCs robustly activated the oncogenic PI3K-AKT signaling in MCF-10AT cells. We also revealed the auto-activated TGF-beta and Wnt pathways in co-cultured MCF-10AT cells, which may be synergistic in tumor formation and progression. As expected, blocking these pathways, especially the PI3K-AKT pathway, strongly diminished the promoting effects of ADSCs, suggesting their potential as therapeutic targets for ADSC grafting-associated breast tumors.

Conclusions: Our data illustrated the synergistic effect between ADSC paracrine factors and MCF-10AT auto-activated pathways in the carcinogenesis of MCF-10AT cells through activation of the oncogenic PI3K-AKT pathway. Based on these findings, we strongly recommend pre-operative examinations for breast cancer risk factors before ADSC-associated transplantation.

References
1.
Katzel E, Bucky L . Fat Grafting to the Breast: Clinical Applications and Outcomes for Reconstructive Surgery. Plast Reconstr Surg. 2017; 140:69S-76S. DOI: 10.1097/PRS.0000000000003945. View

2.
Marra A, Viale G, Pileri S, Pravettoni G, Viale G, De Lorenzi F . Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treat Rev. 2020; 84:101963. DOI: 10.1016/j.ctrv.2020.101963. View

3.
Mizuno H, Hyakusoku H . Fat grafting to the breast and adipose-derived stem cells: recent scientific consensus and controversy. Aesthet Surg J. 2010; 30(3):381-7. DOI: 10.1177/1090820X10373063. View

4.
Qin Y, Ge G, Yang P, Wang L, Qiao Y, Pan G . An Update on Adipose-Derived Stem Cells for Regenerative Medicine: Where Challenge Meets Opportunity. Adv Sci (Weinh). 2023; 10(20):e2207334. PMC: 10369252. DOI: 10.1002/advs.202207334. View

5.
Domenis R, Lazzaro L, Calabrese S, Mangoni D, Gallelli A, Bourkoula E . Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques. Stem Cell Res Ther. 2015; 6:2. PMC: 4417272. DOI: 10.1186/scrt536. View